2021 marked a successful year for the protein degradation field with several candidates entering the clinic. As the European centric targeted protein degradation landscape matures and the number of pre-clinical candidates expected to enter clinical development in the next year grows ever more, the 2nd TPD Europe Summit returns to highlight key challenges and opportunities ahead.
Built with biopharma in mind, join us as we take a deep dive into how European leaders of protein degradation are approaching key translational challenges including optimisation of selectivity, bioavailability and PKPD to ensure the safety, efficacy and potency of their clinical pipelines in 2022 and beyond.
Be at the heart of the discussion by joining 180+ Senior Scientists, Principal Investigators & Heads of Discovery, Pre-Clinical & Translational Development from Europe and around the globe for two dedicated streams of exciting content over three days to capitalise on this emerging therapeutic class.
Download the event guide to check out our expert speaker faculty and what will be discussed.
Snapshot of Our 2022 World Class Speaker Faculty
Health & Safety
Joining From Outside the UK?
Those arriving in the UK no longer need to isolate until receipt of a negative PCR test.
The health, safety and well-being of our community remains our highest priority, therefore, a lateral flow test must be performed within 24 hours of the conference starting and you may be asked to provide proof of a negative result before entering.
Full H&S details can be found in your event guide here.